findmyKOL

Chandrasekar Palaniswamy, MD

Basic profile

Saint Agnes Medical Center

ORCIDNPI
RegionFresno, CA · WestSpecialtyClinical Cardiac ElectrophysiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Chandrasekar Palaniswamy is a Cardiology physician affiliated with Saint Agnes Medical Center. OpenAlex indexes 187 publications with 3,515 citations (h-index 31).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
187publications

Distinct works indexed by OpenAlex, matched via ORCID.

3,515citations

Total citations across indexed works.

31h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
37companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1207 E Herndon Ave
Fresno, CA 937203235

Telephone

559-432-4303

Provider last certified this registry record 26 Apr 2024.

View the NPPES registry record

Industry payments

37 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    80.4%
    Beta blocker18%
    Metoprolol Succinate56%Carvedilol32%Metoprolol Tartrate8%Atenolol1%Nebivolol Hcl1%Sotalol1%Propranolol Hcl1%
    Part D<11 patients
    Statin16.7%
    Atorvastatin Calcium67%Rosuvastatin Calcium28%Simvastatin3%Pravastatin Sodium1%Lovastatin1%Pitavastatin Calcium1%
    Part D<11 patients

    + 21 more classes in this area

  • Blood & clotting

    12.7%
    Factor Xa inhibitor10.2%
    Eliquis83%Xarelto17%
    Part D247 patients
    P2Y12 inhibitor2%
    Clopidogrel100%
    Part D88 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    6%
    Potassium supplement3.3%
    Potassium Chloride86%Klor-Con 1014%
    Part D89 patients
    SGLT2 inhibitor2.6%
    Jardiance57%Farxiga43%
    Part D45 patients

    + 1 more class in this area

Where care is delivered (Part B)42.4% facility · 57.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”